#TIME trial: randomised trial in more than 21,000 patients with high blood pressure has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.
#ESCCongress
#PERSPECTIVE trial: sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with #heartfailure and mildly reduced or preserved ejection fraction.
#ESCCongress
#ADVOR trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated #heartfailure.
#ESCCongress
#DANFLU_1 trial: Innovative randomised trial shows high-dose influenza vaccination in older adults is associated with a reduced risk of death and lower incidence of hospitalisation for influenza or pneumonia compared with standard-dose vaccination.
#ESCCongress
#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease.
#ESCCongress
#EchoNet_RCT: In patients undergoing echocardiographic evaluation of #cardiac function, preliminary assessment by artificial intelligence is superior to initial sonographer assessment.
#ESCCongress
#eBRAVE_AF trial: #AFib screening using conventional smartphones more than doubles the detection and treatment rate in older people compared to routine screening.
#ESCCongress
A new ESC association is born!
CCNAP has now become the Association of Cardiovascular Nursing and Allied Professionals.
It is testament to their dedication and expertise in caring for patients. Well done everyone!
#ACNAP#ESCCongress
#ESCCongress: watch The VERDICT https://t.co/NzbOm5ZrQY. In patients with NSTEACS, this randomised controlled trial tested the hypothesis, that a strategy of early invasive coronary angiography and possible revascularization conducted within 12 hours is superior to...